1. Home >
  2. Companies >
  3. Private >
  4. Life Science >
  5. United States >
  6. Florida >
  7. Noven Pharmaceuticals >
  8. M&A

Noven Pharmaceuticals Mergers & Acquisitions

Noven Pharmaceuticals M&A Summary

Noven Pharmaceuticals has acquired 2 companies. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.

Noven Pharmaceuticals’ largest acquisition to date was in 2007, when it acquired JDS Pharmaceuticals for $187M. It’s largest disclosed sale occurred in 2014, when it sold Noven Therapeutics - NDA Lithobid to ANI Pharmaceuticals for $12M. Noven Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 3

Noven Pharmaceuticals, Inc.

11960 S.W. 144th Street ,
Miami, Florida 33186
United States,
(305)253-5099
www.noven.com

All (2) Buy (1) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2014-07-01 Noven Therapeutics - NDA Lithobid · Life Science
, United States

Noven Therapeutics - NDA Lithobid comprises the pharmaceutical preparation Lithobid, a 300 mg tablet with lithium carbonate extended release.

12 Divestiture

ANI Pharmaceuticals

Noven Pharmaceuticals, Inc.


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal